Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers: The Cooper Center Longitudinal Study

Amanda B. Peel, Carolyn E. Barlow, David Leonard, Laura F. DeFina, Lee W. Jones, Susan G. Lakoski

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background Cardiorespiratory fitness (CRF), a strong predictor of mortality, is impaired among cancer patients. There is limited data, however, regarding CRF levels in women diagnosed with gynecologic cancers. Methods We compared CRF among ovarian, endometrial, and cervical cancer cases (n = 89) to age-matched controls (n = 89) in the Cooper Center Longitudinal Study (CCLS). CRF was evaluated by a maximal treadmill exercise tolerance test using a modified-Balke protocol. Conditional logistic regression was used to test for case-control differences in cardiorespiratory fitness, after controlling for age and body mass index, and adhering to the matched pairs design. Results The mean ages of cancer cases and controls were 50.9 years and 51.1 years, respectively (p = 0.81). Peak METs (1 MET = 3.5 mL kg<sup>- 1</sup> min<sup>- 1</sup>) were 9.2 ± 2.0 in cancer cases compared to 10.0 ± 2.2 in controls (p = 0.03). When stratifying by type of cancer, peak METs were 8.9 ± 2.2, 8.4 ± 1.9, 9.5 ± 2.0 for patients with ovarian, endometrial, and cervical cancer, respectively. A gynecological cancer diagnosis was associated with greater odds of having 1-MET lower CRF compared to controls (OR 1.31, 95% CI: 1.05-1.64, p = 0.018), after controlling for age and BMI. Conclusion Gynecologic cancer survivors were more likely to have a 1-MET lower CRF than controls. Given a 1-MET change in CRF is associated with a significant, we advocate for more robust research regarding CRF in gynecologic cancer patients.

Original languageEnglish (US)
Pages (from-to)394-397
Number of pages4
JournalGynecologic Oncology
Volume138
Issue number2
DOIs
StatePublished - Aug 1 2015

Fingerprint

Endometrial Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms
Longitudinal Studies
Survivors
Neoplasms
Cardiorespiratory Fitness
Exercise Tolerance
Exercise Test
Body Mass Index
Logistic Models
Mortality
Research

Keywords

  • Cardiorespiratory fitness
  • Cervical cancer
  • Endometrial cancer
  • Gynecologic cancer
  • Ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers : The Cooper Center Longitudinal Study. / Peel, Amanda B.; Barlow, Carolyn E.; Leonard, David; DeFina, Laura F.; Jones, Lee W.; Lakoski, Susan G.

In: Gynecologic Oncology, Vol. 138, No. 2, 01.08.2015, p. 394-397.

Research output: Contribution to journalArticle

Peel, Amanda B. ; Barlow, Carolyn E. ; Leonard, David ; DeFina, Laura F. ; Jones, Lee W. ; Lakoski, Susan G. / Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers : The Cooper Center Longitudinal Study. In: Gynecologic Oncology. 2015 ; Vol. 138, No. 2. pp. 394-397.
@article{6207154dd2b44cb5a1eb729452cbc888,
title = "Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers: The Cooper Center Longitudinal Study",
abstract = "Background Cardiorespiratory fitness (CRF), a strong predictor of mortality, is impaired among cancer patients. There is limited data, however, regarding CRF levels in women diagnosed with gynecologic cancers. Methods We compared CRF among ovarian, endometrial, and cervical cancer cases (n = 89) to age-matched controls (n = 89) in the Cooper Center Longitudinal Study (CCLS). CRF was evaluated by a maximal treadmill exercise tolerance test using a modified-Balke protocol. Conditional logistic regression was used to test for case-control differences in cardiorespiratory fitness, after controlling for age and body mass index, and adhering to the matched pairs design. Results The mean ages of cancer cases and controls were 50.9 years and 51.1 years, respectively (p = 0.81). Peak METs (1 MET = 3.5 mL kg- 1 min- 1) were 9.2 ± 2.0 in cancer cases compared to 10.0 ± 2.2 in controls (p = 0.03). When stratifying by type of cancer, peak METs were 8.9 ± 2.2, 8.4 ± 1.9, 9.5 ± 2.0 for patients with ovarian, endometrial, and cervical cancer, respectively. A gynecological cancer diagnosis was associated with greater odds of having 1-MET lower CRF compared to controls (OR 1.31, 95{\%} CI: 1.05-1.64, p = 0.018), after controlling for age and BMI. Conclusion Gynecologic cancer survivors were more likely to have a 1-MET lower CRF than controls. Given a 1-MET change in CRF is associated with a significant, we advocate for more robust research regarding CRF in gynecologic cancer patients.",
keywords = "Cardiorespiratory fitness, Cervical cancer, Endometrial cancer, Gynecologic cancer, Ovarian cancer",
author = "Peel, {Amanda B.} and Barlow, {Carolyn E.} and David Leonard and DeFina, {Laura F.} and Jones, {Lee W.} and Lakoski, {Susan G.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.ygyno.2015.05.027",
language = "English (US)",
volume = "138",
pages = "394--397",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers

T2 - The Cooper Center Longitudinal Study

AU - Peel, Amanda B.

AU - Barlow, Carolyn E.

AU - Leonard, David

AU - DeFina, Laura F.

AU - Jones, Lee W.

AU - Lakoski, Susan G.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Background Cardiorespiratory fitness (CRF), a strong predictor of mortality, is impaired among cancer patients. There is limited data, however, regarding CRF levels in women diagnosed with gynecologic cancers. Methods We compared CRF among ovarian, endometrial, and cervical cancer cases (n = 89) to age-matched controls (n = 89) in the Cooper Center Longitudinal Study (CCLS). CRF was evaluated by a maximal treadmill exercise tolerance test using a modified-Balke protocol. Conditional logistic regression was used to test for case-control differences in cardiorespiratory fitness, after controlling for age and body mass index, and adhering to the matched pairs design. Results The mean ages of cancer cases and controls were 50.9 years and 51.1 years, respectively (p = 0.81). Peak METs (1 MET = 3.5 mL kg- 1 min- 1) were 9.2 ± 2.0 in cancer cases compared to 10.0 ± 2.2 in controls (p = 0.03). When stratifying by type of cancer, peak METs were 8.9 ± 2.2, 8.4 ± 1.9, 9.5 ± 2.0 for patients with ovarian, endometrial, and cervical cancer, respectively. A gynecological cancer diagnosis was associated with greater odds of having 1-MET lower CRF compared to controls (OR 1.31, 95% CI: 1.05-1.64, p = 0.018), after controlling for age and BMI. Conclusion Gynecologic cancer survivors were more likely to have a 1-MET lower CRF than controls. Given a 1-MET change in CRF is associated with a significant, we advocate for more robust research regarding CRF in gynecologic cancer patients.

AB - Background Cardiorespiratory fitness (CRF), a strong predictor of mortality, is impaired among cancer patients. There is limited data, however, regarding CRF levels in women diagnosed with gynecologic cancers. Methods We compared CRF among ovarian, endometrial, and cervical cancer cases (n = 89) to age-matched controls (n = 89) in the Cooper Center Longitudinal Study (CCLS). CRF was evaluated by a maximal treadmill exercise tolerance test using a modified-Balke protocol. Conditional logistic regression was used to test for case-control differences in cardiorespiratory fitness, after controlling for age and body mass index, and adhering to the matched pairs design. Results The mean ages of cancer cases and controls were 50.9 years and 51.1 years, respectively (p = 0.81). Peak METs (1 MET = 3.5 mL kg- 1 min- 1) were 9.2 ± 2.0 in cancer cases compared to 10.0 ± 2.2 in controls (p = 0.03). When stratifying by type of cancer, peak METs were 8.9 ± 2.2, 8.4 ± 1.9, 9.5 ± 2.0 for patients with ovarian, endometrial, and cervical cancer, respectively. A gynecological cancer diagnosis was associated with greater odds of having 1-MET lower CRF compared to controls (OR 1.31, 95% CI: 1.05-1.64, p = 0.018), after controlling for age and BMI. Conclusion Gynecologic cancer survivors were more likely to have a 1-MET lower CRF than controls. Given a 1-MET change in CRF is associated with a significant, we advocate for more robust research regarding CRF in gynecologic cancer patients.

KW - Cardiorespiratory fitness

KW - Cervical cancer

KW - Endometrial cancer

KW - Gynecologic cancer

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=84938200619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938200619&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2015.05.027

DO - 10.1016/j.ygyno.2015.05.027

M3 - Article

C2 - 26026734

AN - SCOPUS:84938200619

VL - 138

SP - 394

EP - 397

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -